drugset / Trial / NCT00109291
Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease
RandomizedParallel-groupTriple-blindTreatment
Summary
To evaluate the safety profile of single intravenous (IV) dose levels of peginesatide in participants with chronic kidney disease(CKD) not on dialysis.
Timeline
- Start
- 2005-03
- Primary completion
- 2006-02
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | peginesatide | Peptide | 0.025 mg/kg | Intravenous |
| Subject | peginesatide | Peptide | 0.05 mg/kg | Intravenous |
| Subject | peginesatide | Peptide | 0.1 mg/kg | Intravenous |